Richard D Mamelok Selected Research

glycopyrronium tosylate

1/2021	Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
8/2019	A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Mamelok Research Topics

Disease

3	Delayed Graft Function 04/2011 - 03/2006
2	Hyperhidrosis 01/2021 - 08/2019
1	Diarrhea 08/2008
1	Bronchiolitis Obliterans Syndrome 04/2006
1	Infections 06/2005

Drug/Important Bio-Agent (IBA)

2	glycopyrronium tosylateIBA 01/2021 - 08/2019
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 08/2019
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2021 - 08/2019
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2011 - 04/2006
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2010
1	AntibodiesIBA 03/2010
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2008
1	GlucuronidesIBA 08/2008
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2008
1	Azathioprine (Imuran)FDA LinkGeneric 04/2006
1	AlbuminsIBA 03/2006
1	Daclizumab (Zenapax)FDA Link 06/2005
1	Monoclonal AntibodiesIBA 06/2005
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 06/2005

Therapy/Procedure

1	Kidney Transplantation 04/2011
1	Transplantation 03/2010
1	Therapeutics 06/2005